STAT1 and neoplasm: We monitored WT and STAT1-/- 129S6/SvEv-strain female mice for tumor development and found that 65% (15 out of 23) of the STAT1-/- mice developed spontaneous mammary adenocarcinomas (median tumor onset of 23 months) but that none of the WT mice developed the disease (Figure 3A).